Suramin, penciclovir, and anidulafungin exhibit potential in the treatment of COVID-19 via binding to nsp12 of SARS-CoV-2.

Dey S, Saini M, Dhembla C, et al. Suramin, penciclovir, and anidulafungin exhibit potential in the treatment of COVID-19 via binding to nsp12 of SARS-CoV-2. Journal of biomolecular structure & dynamics. 2021:1-17. doi:10.1080/07391102.2021.2000498.